In race to develop obesity drugs, Roche acquires California biotech for $2.7B – Inside INdiana Business insideindianabusiness.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from insideindianabusiness.com Daily Mail and Mail on Sunday newspapers.
The company, Carmot Therapeutics, has numerous drugs under development. Its lead asset is a once-a-week injection that is in mid-stage development for the treatment of obesity.
The Food and Drug Administration has authorized Zepbound, which is manufactured by Eli Lilly, approval to be prescribed as a weight-management treatment, paving the way for more people to gain access to the medication.
Point Biopharma insiders to reap millions from Lilly deal – Inside INdiana Business insideindianabusiness.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from insideindianabusiness.com Daily Mail and Mail on Sunday newspapers.